Brief: Lifemd Launches Testorx, A New Rex MD Direct-To-Consumer Testosterone Replacement Therapy Telehealth Offering
23/10/2024 15:31
Oct 23 (Reuters) - LifeMD Inc LFMD.O :
* LIFEMD® LAUNCHES TESTORX, A NEW REX MD® DIRECT-TO-CONSUMER
TESTOSTERONE REPLACEMENT THERAPY TELEHEALTH OFFERING
Source text for Eikon: ID:nGNX7kVGtT
Further company coverage: LFMD.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on LifeMD
See all newsLifeMD Inc reports results for the quarter ended June 30 - Earnings Summary
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs
Brief: LifeMD Inc Q2 Revenue USD 47.3 Million Vs. IBES Estimate USD 49.2 Million
LifeMD Inc expected to post a loss of 15 cents a share - Earnings Preview
LifeMD Q1 revenue beats estimates on record telehealth subscriber additons